Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity-Reference-Cited by-同舟云学术

Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity

Published:2020-09 Issue: Volume:18 Page:259-268
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Pei Xiaolei,Shao Wenwei,Xing Allene,Askew Charles,Chen Xiaojing,Cui Caibin,Abajas Yasmina L.,Gerber David A.,Merricks Elizabeth P.,Nichols Timothy C.,Li Wuping,Samulski R. Jude,Li Chengwen

Funder

North Carolina Biotechnology Center

National Institutes of Health

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference33 articles.

1. Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial;Cwerman-Thibault;C R Biol.,2014

2. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B;Nathwani;N. Engl. J. Med.,2011

3. Gene therapy for haemophilia B;Tuddenham;Haemophilia,2012

4. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant;George;N. Engl. J. Med.,2017

5. Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy;Hurlbut;Mol. Ther.,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of full and empty particles of adeno-associated virus vectors via a novel dual fluorescence-linked immunosorbent assay;Molecular Therapy - Methods & Clinical Development;2024-09

2. Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy;Current Gene Therapy;2024-08

3. An investigation of the immune epitopes of adeno-associated virus capsid-derived peptides among hemophilia patients;Molecular Therapy - Methods & Clinical Development;2024-06

4. Rationally engineered novel AAV capsids for intra-articular gene delivery;Molecular Therapy - Methods & Clinical Development;2024-03

5. Circumventing B Cell Responses to Allow for Redosing of Adeno-Associated Virus Vectors;Human Gene Therapy;2023-12-06